Myelodysplasia and Naxos disease: a novel pathogenetic association?
- 28 October 2002
- journal article
- other
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 16 (11), 2335-2337
- https://doi.org/10.1038/sj.leu.2402587
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)The Lancet, 2000
- Plakoglobin Regulates the Expression of the Anti-apoptotic Protein BCL-2Journal of Biological Chemistry, 2000
- Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer.Journal of Clinical Oncology, 1998
- Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathwaysCurrent Opinion in Cell Biology, 1997
- Forty-four cases of childhood myelodysplasia with cytogenetics, documented by the Groupe Français de Cytogénétique HématologiqueLeukemia, 1997
- Expression of Cadherin-Catenin Complexes in Human Leukemia Cell LinesThe Journal of Biochemistry, 1996
- Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin.The Journal of cell biology, 1996
- The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers.Proceedings of the National Academy of Sciences of the United States of America, 1995